supported by the General Program of the National Natural Science Foundation of China (Grant No. 82073376)。
Pseudomyxoma peritonei(PMP) is an indolent malignant syndrome. The standard treatment for PMP is cytoreductive surgery combined with intraperitoneal hyperthermic chemotherapy(CRS + HIPEC). However, the high recurrence...
supported by the Applied Basic Research Programs of Science and Technology Commission Foundation of Jiangsu Province(No.BE2015684).
Approximately 30%–40%of growth hormone–secreting pituitary adenomas(GHPAs)harbor somatic activating mutations in GNAS(αsubunit of stimulatory G protein).Mutations in GNAS are associated with clinical features of sm...